The study emphasizes the importance of Knoevenagel condensation for forming carbon—carbon bonds to create biologically active α, β-unsaturated compounds. In this research, arylidenemalononitriles (AMN) (1–4) and ethyl 2-cyano-3-phenylacrylates (ECPA) (5–7) analogs were used to test the antibacterial efficacy against five human pathogens. Most of the compounds exhibited moderate to low inhibitory activity, whereas compounds 2 and 6 showed significant antibacterial effects, notably surpassing ampicillin in efficacy against Bacillus cereus and Escherichia coli. Molecular docking studies revealed strong binding affinities for these compounds (1–7) with bacterial proteins i.e., 1AH7 (−6.9 kcal/mol to −8.6 kcal/mol) and 6DR3 (−5.8 kcal/mol to −7.7 kcal/mol) respectively, indicating effective ligand–protein interactions. Structural analysis highlighted that specific functional groups showed enhance binding affinity, while PASS and ADMET predictions suggested favorable biological profiles for all compounds. The findings were corroborated by molecular dynamics simulations via NMA analyses and quantum chemical calculations, demonstrating strong agreement between experimental and computational results.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
3.67 MB
0.00 MB